Autonomix Medical宣布定价500万美元私募

2025-11-18 21:59

Autonomix Medical (NASDAQ:AMIX) stated on Tuesday that it has entered into an agreement with a single institutional investor to purchase 4.5M shares of common stock and, together with unregistered Series C warrants, to purchase up to an aggregate 9M shares of common stock, in a private placement priced at the market under Nasdaq rules.
The combined offering price for each share of common stock and Series C warrant is $1.1107.
The Series C warrants will have an exercise price of $0.8607 per share, will be exercisable immediately, and will expire on the five-and-one-half-year from the date of issuance.
The gross proceeds from the offering are estimated to be approximately $5M.
The offering is expected to close on or about November 19, 2025.
Maxim Group LLC is acting as the sole placement agent in connection with the offering.
Shares +58.18%.

More on Autonomix Medical, Inc.